20368 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Non condensed pyridines; Hydrogenated derivatives thereof 1,4-Dihydropyridines, e.g. nifedipine, nicardipine
Use of atpenin to activate innate immunity
#302Small molecule therapeutic compounds that reduce the incidence of intracerebral hemorrhage and brain microhemorrhages
#303Pharmaceutical for prophylaxis or treatment of hypertension
#304Inhibitors of the renal outer medullary potassium channel
#305Trimegestone (TMG) for treatment of preterm birth
#306ORALLY-DISSOLVING FILMS FOR DRUG DELIVERY THROUGH THE ORAL CAVITY
#307Compositions and methods for treating pelvic pain and other conditions
#308Treatment of solid tumours
#309Method for treating lymphedema
#310CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS
#311INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GOUT AND PREPARATION METHOD THEREOF
#312UNIFORM FILMS FOR RAPID DISSOLVE DOSAGE FORM INCORPORATING TASTE-MASKING COMPOSITIONS
#313Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis
#314INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
#315Mast cell stabilizers treatment for systemic disorders
#316Methods for treating cancer using iNOS-inhibitory compositions
#317Abuse-proofed dosage form
#318METHOD AND APPARATUS FOR ADMINISTERING NITRIC OXIDE WITH SUPPLEMENTAL DRUGS
#319INJECTABLE AND IMPLANTABLE CARRIER SYSTEMS BASED ON MODIFIED POLY(DICARBOXYLIC ACID MULTI-OIL ESTERS) FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENT
#320APPLICATION OF LARGE-DOSE GLYCERINUM IN FREEZE-THAWING TOLERABLE LIPID EMULSION
#321Small molecule efflux pump inhibitors
#322Clevidipine nanoparticles and pharmaceutical compositions thereof
#323Solid dispersion
#324METHODS AND COMPOUNDS FOR CALCIUM ION CHANNEL REGULATION
#325Self-supporting films for pharmaceutical and food use
#326Pharmaceutical combination formulation comprising amlodipine, losartan and rosuvastatin
#327INOS-INHIBITORY COMPOSITIONS AND THEIR USE AS BREAST CANCER THERAPEUTICS
#328ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY
#329Mast cell stabilizers treatment for systemic disorders
#330Mast cell stabilizers treatment for systemic disorders
#331Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
#332CARRIER COMPOSITION
#333NOVEL FORMULATIONS FOR TREATMENT OF PAIN, NEUROPATHY, WOUNDS, AND ULCERS
#334SUSTAINED RELEASE FORMULATION
#335Systems and methods for sympathetic cardiopulmonary neuromodulation
#336Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
#337Inhibitors of the renal outer medullary potassim channel
#338Ex vivo methods for predicting and confirming in vivo metabolism of pharmaceutically active compounds
#339Hydrogel polymeric compositions and methods
#340Composition
#341BETA-CATENIN
#342COMPOSITE FORMULATION COMPRISING TADALAFIL AND AMLODIPINE
#343Method for treating hypertension
#344Delayed release pharmaceutical formulation containing porous carrier particles for colon targeting
#345Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis
#346PHARMACEUTICAL FOR PROPHYLAXIS OR TREATMENT OF HYPERTENSION
#347Crush resistant delayed-release dosage forms
#348Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures
#349Cooperative Medication Combination Systems
#350Thiazole Inner Salt Compounds, and Preparation Methods and Uses Thereof
#351Topical therapeutic formulations
#352CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS
#353Targeted delivery of drugs to the myometrium via anti-oxytocin receptor antibodies
#354Topical therapeutic formulations
#355Composition for hot melt extrusion and method for producing hot melt extrudate by using same
#356Solid dosage form containing arabinogalactan
#357Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
#358Methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptide
#359Pre-eclampsia biomarkers
#360Inhibitors of the renal outer medullary potassium channel
#361COMPOSITIONS AND METHODS FOR PHYSIOLOGICAL DELIVERY USING CANNABIDIOL
#362Controlled release compositions
#363Inhibitors of the renal outer medullary potassium channel
#364STABLE PHARMECEUTICAL COMPOSITION OF AMLODIPINE AND BENAZEPRIL OR SALTS THEREOF
#365Therapeutic Composition for the Treatment of Perianal Disorders
#366Use of inhibitors of acid sphingomyelinase to treat acquired and inherited retinal degenerations
#367OLIGOMER-CALCIUM CHANNEL BLOCKER CONJUGATES
#368COMPOSITIONS FOR PROMOTION OF WOUND HEALING AND/OR SCAR REDUCTION
#369Neuronal pain pathway
#370Inhibitors of the renal outer medullary potassium channel
#371Inhalation-type pharmaceutical composition for the treatment of arthritis and preparation method thereof
#372Inhalation-type pharmaceutical composition for the treatment of heart disease and preparation method thereof
#373Inhalation-type pharmaceutical composition for the treatment of Alzheimer's disease and preparation method thereof
#374Inhalation-type pharmaceutical composition for the treatment of Parkinson's disease and preparation method thereof
#375Therapeutic approaches for treating Parkinson's disease
#376SOLID PREPARATION COMPRISING ENTERIC SOLID DISPERSION
#377Aqueous drug delivery system
#378Methods to inhibit intracellular growth of bacteria and to treat bacteria-mediated diseases
#379UNIFORM FILMS FOR RAPID DISSOLVE DOSAGE FORM INCORPORATING TASTE-MASKING COMPOSITIONS
#380Topical therapeutic formulations
#381Compositions and methods for treating pelvic pain and other conditions
#382Nanoclusters compositions and methods
#383Tablet dosage form
#384Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations
#385Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate
#386Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures
#387Topical compositions to treat circulatory disorders
#388Foamable Compositions and Kits Comprising One or More of a Channel Agent, a Cholinergic Agent, A nitric Oxide Donor and Related Agents and Their Uses
#389Clevidipine emulsion formulations containing antimicrobial agents
#390Compositions for increasing hair growth
#391Hydrogel polymeric compositions and methods
#392Composition for hot-melt extrusion and method for producing hot-melt extrusion product using same
#393Controlled release formulations of nisoldipine
#394Pharmaceutical composition for preventing or treating hyperlipidemia
#395Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
#396Inhibitors of the renal outer medullary potassium channel
#397METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#3981,4-dihydropyridine derivatives with Hsp modulating activity
#399Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (SCNxA) with small molecules
#400Oral disintegrating tablet
#401Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
#402Polymorph compositions, methods of making, and uses thereof
#403Methods for Treating Osteoarthritis
#404THERAPEUTIC COMPOSITION FOR THE TREATMENT OF PERIANAL DISORDERS
#405Compositions and methods of treating gliomas
#406Composite formulation comprising a tablet encapsulated in a hard capsule
#407Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures
#408Combinations with 2-aminoethanesulfonic acid
#409Compositions of nicardipine and sulfoalkylated β-cyclodextrin
#410Phenylethanolamine-based NMDA receptor antagonists
#411Trimegestone (TMG) for treatment of preterm birth
#412Methods for controlling blood pressure and reducing dyspnea in heart failure
#413TRANSDERMAL DELIVERY SYSTEM KIT
#414Drug delivery systems comprising solid solutions of weakly basic drugs
#415PRAMIPEXOLE TRANSDERMAL DELIVERY FOR SEVERE HEADACHES
#416THERAPEUTIC COMBINATION
#417ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY (2)
#418PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING LOW IMPURITY CONCENTRATIONS OF THE SAME
#419Methods and compositions for treating bacterial infections with iron chelators
#420Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
#421Polymorph compositions, methods of making, and uses thereof
#422PHARMACEUTICAL COMPOSITES OF POORLY WATER SOLUBLE DRUGS AND POLYMERS
#423Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
#424CYANOACRYLATE-BASED BIO-ADHESIVE COMPOSITION
#425Methods and devices for providing prolonged drug therapy
#426Topical therapeutic formulations
#427Methods and devices for providing prolonged drug therapy
#428Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it
#429THERAPEUTIC COMBINATION
#430COMBINATION THERAPIES FOR TREATING NEUROLOGICAL DISORDERS
#431Antibacterial agents
#432Cellulosic gel material as a pharmaceutical excipient
#433PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION
#434METHODS FOR INHIBITING PRETERM LABOR AND UTERINE CONTRACTILITY DISORDERS AND PREVENTING CERVICAL RIPENING
#435COMPOUND PREPARATION AND ITS USES FOR PREVENTION AND TREATMENT OF HEARING IMPAIRMENT
#436PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING LOW IMPURITY CONCENTRATIONS OF THE SAME
#437Ion-Channel Regulator Compositions and Methods of Using Same
#438PHANTOM PHENOMENA TREATMENT
#439Neuronal pain pathway
#440Oral Preparation Having Improved Quality
#441Phenylethanolamine-based NMDA receptor antagonists
#442CICLETANINE IN COMBINATION WITH ORAL ANTIDIABETIC AND/OR BLOOD LIPID-LOWERING AGENTS AS A COMBINATION THERAPY FOR DIABETES AND METABOLIC SYNDROME
#443Methods and compositions for maintaining active agents in intra-articular spaces
#444PHARMACEUTICAL EXCIPIENT, METHOD FOR ITS PREPARATION AND USE THEREOF
#445Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
#446Method for treating osteoarthritis
#447Antihypertensive pharmaceutical composition
#448Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
#449Method and compositions for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker
#450CYCLOOXYGENASE INHIBITOR AND CALCIUM CHANNEL ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN UROLOGICAL PROCEDURES
#451METHOD FOR PRODUCING PULVERIZED ORGANIC COMPOUND PARTICLE
#452PRE-MIXED, READY-TO-USE IV BOLUS NICARDIPINE COMPOSITIONS AND METHODS OF USE
#453THERAPEUTIC COMBINATION
#454Floating microgranules
#455CARRIER COMPOSITION
#456SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING THE SAME
#457Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
#458COMBINED PREPARATION FOR USE AS A MEDICAMENT
#459Compositions and Methods for Improving Prognosis of a Human with Subarachnoid Hemorrhage
#460Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
#461ANTIBACTERIAL AGENTS
#462Aqueous drug delivery system
#463MULTI-LAYER TABLET COMPRISING EFFERVESCENT LAYER
#464PHARMACEUTICAL COMPOSITIONS OF VALSARTAN
#465Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
#466Combination therapy for the treatment of multiple myeloma
#467Dissolution properties of drug products containing olmesartan medoxomil
#468Therapeutic or prophylactic agent for dyskinesia
#469LEVAMLODIPINE COMPOUND PHARMACEUTICAL COMPOSITION
#470Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and/or a diuretic
#471Controlled-Released Osmotic Pump Tablet with Lubricating Layer and the Preparation Thereof
#472Compositions Comprising Multiple Bioactive Agents, and Methods of Using the Same
#473Compositions comprising a calcium channel blocker or a calmodulin blocker for use in the removal of hyperplastic skin lesions
#474PHARMACEUTICAL COMPOSITION OF LEVAMLODIPINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND β RECEPTOR BLOCKING AGENT, AND USE THEREOF
#475AQUEOUS ORAL PREPARATION OF STABLE AMLODIPINE
#476Antihypertensive pharmaceutical composition
#477Solid pharmaceutical composition comprising amlodipine and losartan
#478Highly efficient and long-acting slow-release formulation of poorly soluble drugs and preparation method thereof
#479Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
#480Solid pharmaceutical composition comprising amlodipine and losartan with improved stability
#481METHOD OF TREATING PERIPHERAL NERVE SENSORY LOSS USING COMPOUNDS HAVING NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY
#482Association of a sinus node if current inhibitor and calcium inhibitor and pharmaceutical compositions containing it
#483Solid pharmaceutical composition
#484Nanocluster compositions and methods
#485TREATMENT OF CARDIOVASCULAR DISEASE AND DYSLIPIDEMIA USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITORS AND SPLA2 INHIBITOR COMBINATION THERAPIES
#486THERAPEUTIC COMBINATION
#487Modified release pharmaceutical compositions
#488Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions
#489Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
#490Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof
#491Oligomer-calcium channel blocker conjugates
#492Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions
#493METHODS AND COMPOSITIONS FOR TREATMENT OF RAYNAUD'S PHENOMENON
#494Potentiators of insulin secretion
#495CICLETANINE IN COMBINATION WITH ORAL ANTIDIABETIC AND/OR BLOOD LIPID-LOWERING AGENTS AS A COMBINATION THERAPY FOR DIABETES AND METABOLIC SYNDROME
#496Methods for treating osteoarthritis
#497Liquid formulation for deferiprone with palatable taste
#498DISSOLUTION PROPERTIES OF DRUG PRODUCTS CONTAINING OLMESARTAN MEDOXOMIL
#499Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc.
#500SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING SAME
#501Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
#502Oral cavity disintegrating tablet and method of producing the same
#503Pharmaceutical compositions of amlodipine and valsartan
#504Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
#505Pharmaceutical Composition Comprising Amlodipine and Losartan
#506MODULATION OF NEUROGENESIS USING D-CYCLOSERINE COMBINATIONS
#507Tablet dosage form
#508Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#509Pharmaceutical compositions for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis
#510Antibacterial agents
#511Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#512THERAPEUTIC COMBINATION
#513Pre-mixed, ready-to-use pharmaceutical compositions
#514CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS
#515Stabilized pharmaceutical compositions containing a calcium channel blocker
#516Stabilized pharmaceutical compositions containing a calcium channel blocker
#517COMPOUNDS THAT INDUCE PANCREATIC BETA-CELL EXPANSION
#518Base for dry solid dispersion, solid dispersion containing the base, and composition containing the dispersion
#519Pharmaceutical Compositions And Methods For Producing Low Impurity Concentrations Of The Same
#520Oral disintegrating tablet
#521Methods and devices for providing prolonged drug therapy
#522MEDICINAL COMPOSITIONS QUICKLY DISINTEGRATING IN THE ORAL CAVITY AND PROCESS FOR PRODUCING THE SAME
#523Modulators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto
#524USE OF COMPOSITION COMPRISING AMLODIPINE IN PREPARING MEDICAMENTS FOR TREATING A LOWER URINARY TRACT DISORDER
#525COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY
#526PRE-MIXED, READY-TO-USE IV BOLUS NICARDIPINE COMPOSITIONS AND METHODS OF USE
#527Method for producing pulverized organic compound particle
#528Method of preventing dihydropyridine compound from degradation
#529Topical composition comprising a dihydropyridine calcium antagonist
#530SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME
#531ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY
#532BRONCHIAL SMOOTH MUSCLE REMODELING INVOLVES CALCIUM-DEPENDENT ENHANCED MITOCHONDRIAL BIOGENESIS IN ASTHMA
#533THERAPEUTIC COMBINATION
#534Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
#535MODIFIED RELEASE FORMULATIONS OF DIHYDROPYRIDINE COMPOUNDS AND METHODS OF MAKING SAME
#536Chronotherapeutic formulations of modified-release calcium channel blocker anti-hypertensive drugs in combination with other anti-hypertensive drugs for 24-hour optimal treatment of hypertension, nocturnal hypertension, and/or hypertension with angina
#537Hydrogel polymeric compositions and methods
#538Association of a sinus node If current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it
#539Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonist
#540Pharmaceutical composition of amlodipine maleate having enhanced stability
#541Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions
#542Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions
#543Solid Dosage Form of Olmesartan Medoxomil And Amlodipine
#544Ion-Channel Regulator Compositions and Methods of Using Same
#545COMPOSITIONS AND METHODS OF TREATMENT USING L-TYPE CALCIUM CHANNEL BLOCKERS AND CHOLINESTERASE INHIBITORS
#546Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations
#547Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A(SPLA) inhibitors and SPLAinhibitor combination therapies
#548METHOD OF TREATMENT OF CARDIAC AND/OR RENAL FAILURE USING A CALCIUM CHANNEL BLOCKER AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR OR AN ANGIOTENSIN II RECEPTOR BLOCKER
#549Solid preparation having improved solubility
#550Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer
#551A3 ADENOSINE RECEPTORS AS TARGETS FOR THE MODULATION OF CENTRAL SEROTONERGIC SIGNALING
#552METHODS OF TREATMENT USING (+)- ISOPROPYL 2-METHOXYETHYL 4-(2-CHLORO-3-CYANO-PHENYL)-1, 4-DIHYDRO-2, 6-DIMETHYL-PYRIDINE-3, 5-DICARBOXYLATE
#553Method for treating a demyelinating condition
#554Adhesive hydrogels for ophthalmic drug delivery
#555Self-supporting films for pharmaceutical and food use
#556Complex Formulation Comprising Amlodipine Camsylate And Simvastatin and Method For Preparation Thereof
#557Rupturing controlled release device comprising a subcoat
#558Use of Hydrochloric Acid For the Manufacture of a Medicament For the Treatment of Hypertension
#559FOAMABLE COMPOSITIONS AND KITS COMPRISING ONE OR MORE OF A CHANNEL AGENT, A CHOLINERGIC AGENT, A NITRIC OXIDE DONOR, AND RELATED AGENTS AND THEIR USES
#560CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM
#561Methods For the Preparation of Stable Pharmaceutical Solid Dosage Forms of Atorvastatin and Amlodipine
#562Method of Treating or Sepsis
#563Stable Solid Dosage Forms of Amlodipine and Benazepril
#564Combination of Organic Compounds
#565Phantom Phenomena Treatment
#566Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters
#567Inhibiting surface enhanced crystallization of amorphous pharmaceuticals with ultrathin coatings
#568Methods for prevention and treatment of diseases causes by hypertension
#569Process
#570Methods for prevention and treatment of arteriosclerosis and restenosis
#571Methods for prevention and treatment of arteriosclerosis, hypertension and restenosis
#572Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid
#573Solid Dosage Forms of Valsartan and Amlo Dipine and Method of Making the Same
#574Inhibiting Cav3 Isoforms and the 25B Splice Varients for the Diagnosis and Treatment of Cancer
#575Means and Methods For Treating a Disease Which is Associated With an Excess Transport of Hyaluronan Across a Lipid Bilayer
#576Treatment of metabolic syndrome with norfluoxetine
#577USE OF CONNECTIVE TISSUE MAST CELL STABILIZERS TO FACILITATE OCULAR SURFACE RE-EPITHELIZATION AND WOUND REPAIR
#578Finely divided composition containing poorly water soluble substance
#579Minicapsule Formulations
#580Complex Formulation Of 3-Hydroxy-3-Methyl Glutaryl Coa Reductace Inhibitor And Antihypertensive Agent, And Process For Preparing Same
#581Pharmaceutical Composition, Method for Producing the Same, and Method for Stabilizing Dihydropyridine Compound in the Pharmaceutical Composition
#582Drug Delivery Systems Comprising Solid Solutions of Weakly Basic Drugs
#583Controlled release nisoldipine compositions
#584Controlled Release Formulations
#585Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors
#586Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
#587Methods of Treatment Using (+)-Isopropyl 2-Ethoxyethyl-4-(2-Chloro-3-Cyano-Phenyl)-1,4-Dihydro-2,6-Dimethyl-Pyridine-3,5-Dicarboxylate
#588Combination Products
#589Dihydropyrimidine Formulations
#590Pre-mixed, ready-to-use pharmaceutical compositions
#591SOLID PREPARATION COMPRISING ENTERIC SOLID DISPERSION
#592Solid dispersion preparation
#593Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
#594PRE-MIXED, READY-TO-USE IV BOLUS COMPOSITIONS AND METHODS OF USE
#595Diagnosis and treatment of human kidney diseases
#596DOSAGE FORMS AND METHODS COMPRISING AMLODIPINE AND CHLORTHALIDONE
#597Combination Therapy
#598Stabilized pharmaceutical compositions containing a calcium channel blocker
#599Association of a sinus node If curent inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it
#600Liquid pharmaceutical compositions of nimodipine